GeoVax Labs, Inc.
General ticker "GOVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $8.4M (TTM average)
GeoVax Labs, Inc. does not follow the US Stock Market performance with the rate: -27.0%.
Estimated limits based on current volatility of 6.4%: low 0.90$, high 1.03$
Factors to consider:
- Earnings expected soon, date: 2026-07-27 amc
- Total employees count: 17 as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Going concern doubt, Operational and conduct risks, Insufficient cash flow, Inability to raise capital, Regulatory and compliance
Short-term GOVX quotes
Long-term GOVX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $3.95MM | $2.49MM |
| Operating Expenses | $26.74MM | $29.10MM | $24.13MM |
| Operating Income | $-26.74MM | $-25.14MM | $-21.64MM |
| Non-Operating Income | $0.78MM | $0.15MM | $0.17MM |
| Interest Expense | $0.00MM | $0.02MM | $0.00MM |
| R&D Expense | $20.72MM | $23.71MM | $18.12MM |
| Income(Loss) | $-25.97MM | $-24.99MM | $-21.46MM |
| Net Income(Loss)* | $-25.97MM | $-24.99MM | $-21.46MM |
| Stockholders Equity | $5.76MM | $5.05MM | $3.83MM |
| Assets | $9.28MM | $8.16MM | $6.34MM |
| Operating Cash Flow | $-25.17MM | $-24.68MM | $-21.47MM |
| Capital expenditure | $0.05MM | $0.02MM | $0.03MM |
| Investing Cash Flow | $-0.05MM | $-0.02MM | $-0.03MM |
| Financing Cash Flow | $4.06MM | $23.75MM | $19.08MM |
| Earnings Per Share** | $-255.59 | $-120.46 | $-22.40 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.